Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Key Highlights: Indication: Adjunct to diet and exercise for adults with hypercholesterolemia, including HeFH Mechanism: Novel, small, high-affinity PCSK9 inhibitor delivering potent LDL-C reduction Efficacy: Phase 3 LIBerate program showed 50% LDL-C lowering with favorable safety Dosing: Once-monthly administration Convenience edge: Room-temperature stability (up to 3 months) and at-home self-administrationno refrigeration required Launch outlook: U.S
Reported results have shown that the addition of pharmacological ascorbate to platinum-based chemotherapy significantly improves tumor deterioration in the advanced stage of NSCLC, by meeting its primary endpoint with an objective response rate of 34.2% and reaching a disease-control rate of 84.2%
For detailed strategies on managing these symptoms, see our complete guide to Retatrutide side effects
How do I know if my side effects are from the dose being too high versus normal adjustment
